Search

Papamichael, Konstantinos, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, et al. 2019. “Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 17 (9): 1655-1668.e3.

Papamichael, Konstantinos, Niels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, Mark T Osterman, and Adam S Cheifetz. 2021. “Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn’s Disease: An ACCENT-II Post Hoc Analysis.”. The American Journal of Gastroenterology 116 (5): 1007-14.

Papamichael, Konstantinos, Vipul Jairath, Guangyong Zou, Benjamin Cohen, Timothy Ritter, Bruce Sands, Corey Siegel, et al. 2022. “Proactive Infliximab Optimisation Using a Pharmacokinetic Dashboard versus Standard of Care in Patients With Crohn’s Disease: Study Protocol for a Randomised, Controlled, Multicentre, Open-Label Study (the OPTIMIZE Trial).”. BMJ Open 12 (4): e057656.

Geeganage, Grace, Ajay Gade, Alessandra Saraga, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Adam S Cheifetz, Laurie B Grossberg, and Konstantinos Papamichael. 2025. “Long-Term Outcomes of Patients With Crohn’s Disease Treated With Risankizumab.”. Inflammatory Bowel Diseases.

Rabinowitz, Loren G, Kira Newman, Elisa Boden, Blaire Burman, Asma Khapra, Aimee L Lucas, and AGA Women’s Committee. 2025. “Gender Equity in Gastroenterology: Perspectives From the AGA Women’s Committee on Current Frameworks and Future Directions.”. Gastroenterology 169 (2): 195-99.

Lee, Jessica D, Konstantinos Papamichael, Lauren T Grinspan, Adam S Cheifetz, Melissa Spiel, Tatyana Kushner, and Loren G Rabinowitz. 2025. “Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver Disease.”. Alimentary Pharmacology & Therapeutics.

Anderson, Kelsey L, Joseph D Feuerstein, and ACP Journal Club Editorial Team at McMaster University. 2026. “GLP-1RAs Increase Risk for Cholelithiasis and GERD But Not Other GI or Biliary Adverse Events Vs. Placebo.”. Annals of Internal Medicine 179 (1): JC11.

Rabinowitz, L G, A Gade, T Deyhim, and J D Feuerstein. 2026. “Safety and Use of IBD Therapies During Pregnancy and Lactation.”. Expert Review of Gastroenterology & Hepatology 20 (2): 81-92.

Merino, Andy Silva-Santisteban, Kevin Enrique Ariza Manzano, Sarah Ballou, Abraham Fourie Bezuidenhout, Katharine A Germansky, and Mandeep S Sawhney. 2026. “Patient Experience With Endoscopic Ultrasound and Magnetic Resonance Cholangiopancreatography for Pancreatic Cancer Screening (The PATRIOT Study).”. Pancreatology : Official Journal of the International Association of Pancreatology (IAP) . [et Al.] 26 (2): 259-64.

Deyhim, Tina, Alessandra Saraga, Ajay Gade, Grace Geeganage, Mostafa A Soliman, Samantha Zullow, Loren G Rabinowitz, et al. 2026. “Lower Drug Clearance of Adalimumab Is Associated With Proactive Therapeutic Drug Monitoring and Mucosal Healing in Patients With Inflammatory Bowel Disease.”. European Journal of Gastroenterology & Hepatology.